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oBackground: We have previously confirmed the
importance of rat chromosome 3 (RNO3) genetic loci on
blood pressure elevation, pulse pressure (PP) variability
and renal pathology during salt challenge in the stroke-
prone spontaneously hypertensive (SHRSP) rat. The aims
of this study were to generate a panel of RNO3 congenic
sub-strains to genetically dissect the implicated loci and
identify positional candidate genes by microarray
expression profiling and analysis of next-generation
sequencing data.
Method and results: A panel of congenic sub-strains
were generated containing Wistar–Kyoto (WKY)-
introgressed segments of varying size on the SHRSP
genetic background, focused within the first 50Mbp of
RNO3. Haemodynamic profiling during salt challenge
demonstrated significantly reduced systolic blood pressure,
diastolic blood pressure and PP variability in SP.WKYGla3a,
SP.WKYGla3c, SP.WKYGla3d and SP.WKYGla3e sub-
strains. Only SBP and DBP were significantly reduced
during salt challenge in SP.WKYGla3b and SP.WKYGla3f
sub-strains, whereas SP.WKYGla3g rats did not differ in
haemodynamic response to SHRSP. Those sub-strains
demonstrating significantly reduced PP variability during
salt challenge also demonstrated significantly reduced renal
pathology and proteinuria. Microarray expression profiling
prioritized two candidate genes for blood pressure
regulation (Dnm1, Tor1b), localized within the common
congenic interval shared by SP.WKYGla3d and
SP.WKYGla3f strains, and one candidate gene for salt-
induced PP variability and renal pathology (Rabgap1),
located within the region unique to the SP.WKYGla3d
strain. Comparison of next-generation sequencing data
identified variants within additional positional genes that
are likely to affect protein function.
Conclusion: This study has identified distinct intervals on
RNO3-containing genes that may be important for blood
pressure regulation and renal pathology during salt
challenge.
Keywords: blood pressure, congenic, gene expression,
next-generation sequencing, profiling, pulse pressure,
radiotelemetry, salt-sensitivity, stroke-prone spontaneously
hypertensive rat, Wistar–Kyoto raturnal of Hypertension
pyright © 2016 Wolters Kluwer Health, Inc. UnauAbbreviations: BP, blood pressure; CMI, cardiac mass
index/indices; DBP, diastolic blood pressure; GWAS,
genome-wide association studies; INDEL, insertions and
deletions of DNA segments; LVMI, left ventricular mass
index/indices; NaCl, sodium chloride; NGS, next-generation
sequencing; PP, pulse pressure; QTL, quantitative trait
locus/loci; RMI, renal mass index/indices; SBP, systolic blood
pressure; SHRSP, stroke-prone spontaneously hypertensive
rat; SNP, single-nucleotide polymorphism; WKY, Wistar–
KyotoINTRODUCTIONL
arge-scale meta-analyses of genome-wide association
studies (GWAS) have successfully identified a num-
ber of loci which achieved genome-wide significance
for their association with blood pressure (BP) [1–7]. These
genetic variants display modest effect sizes and explain
only a small percentage of BP variability, suggesting that
many more BP-related variants remain to be discovered
[8,9]. Genetic studies in appropriate inbred rodent models
offer a complementary approach for the discovery of
genetic elements contributing to this missing heritability.
Multiple BP loci have previously been identified by
linkage analysis on rat chromosome 3 (RNO3) [10–17].
We have previously utilized congenic (SP.WKYGla3a) andreproduction in any medium, provided the original work is properly cited.
DOI:10.1097/HJH.0000000000001155
www.jhypertension.com 1
thorized reproduction of this article is prohibited.
CE: Swati; JH-D-16-00546; Total nos of Pages: 11;
JH-D-16-00546
Koh-Tan et al.bicongenic (SP.WKYGla2a/3a) strains generated on the
stroke-prone spontaneously hypertensive (SHRSP) genetic
background to confirm the importance of RNO3 genetic
loci on BP elevation, pulse pressure (PP) variability and
renal pathology during baseline and salt-challenge periods
[18]. In this previous study, the introgressed congenic
interval within the SP.WKYGla3a strain was large, spanning
155.4Mbp and encompassing approximately 85% of the
length of RNO3. In order to determine the underlying
genetic elements and to begin identifying the mechanistic
basis of the haemodynamic changes and renal pathology,
it was necessary to dissect this large congenic interval.
The aims of this study were to generate a panel of
RNO3-congenic sub-strains to dissect the SP.WKYGla3a
interval, focusing, in particular, on the 50-Mbp region at
the top of RNO3, because previous linkage analysis
indicated a significant quantitative trait locus (QTL) peak
within this region [17]. Secondly, we aimed to identify
positional candidate genes for BP variation by comparison
of microarray expression profiling in the parental strains
and two congenic sub-strains selected for their contrasting
phenotype. In addition, we have utilized high-throughput
next-generation sequencing (NGS) data for SHRSPGla and
WKYGla strains to identify sequence variants within the
implicated congenic intervals that have potential functional
importance.
METHODS
Animal strains
All animal procedures performed were approved by the
Home Office according to regulations regarding exper-
iments with animals in the United Kingdom. Inbred colo-
nies of SHRSP and WKY rats have been developed and
maintained at the University of Glasgow since 1991, as
described previously [18,19]. All animals were housed
under controlled environmental conditions, fed standard
rat chow (rat and mouse no. 1 maintenance diet, Special
Diet Services) and water provided ad libitum. The RNO3-
congenic strain, SP.WKYGla3a (D3Mgh16-D3Wox28), is a
previously published strain [18]. Genotyping was carried
out as previously described using genomic DNA isolated
from a 4-mm ear notch at weaning [19]. Congenic sub-
strains were generated by backcrossing male SP.WKYGla3a
rats to SHRSP females. Progeny generated from this
backcross were heterozygous throughout the original con-
genic interval. Brother  sister mating was carried out
to generate sub-strains containing smaller congenic inter-
vals: SP.WKYGla3b (D3Wox20-D3Rat114), SP.WKYGla3c
(D3Mgh16-D3Rat80), SP.WKYGla3d (D3Mgh16-D3Wox3),
SP.WKYGla3e (D3Mgh16-rs65433898), SP.WKYGla3f (D3
Mgh16-rs197649383), and SP.WKYGla3g (D3Mgh16-
D3Mit10) (Fig. 1). A full list of microsatellite markers used
for genotyping is shown in Supplementary Table 1 (http://
links.lww.com/HJH/A685). Markers and SNPs are mapped
using Genome Assembly RGSC 3.4 since this assembly was
used to determine the sequences of the RNO3 region in
SHRSPGla andWKYGla rats. The nomenclature of the strains
consists of the first abbreviation belonging to the recipient
strain and the second to the donor: Gla denotes that strains
originate from the Glasgow colonies, and the number2 www.jhypertension.com
Copyright © 2016 Wolters Kluwer Health, Inc. Unau3 refers to RNO3. All of the studies were conducted in
male rats only.
Haemodynamic and phenotypic measurements
The Dataquest IV telemetry system (Data Sciences Inter-
national, St Paul, Minnesota, USA) was used for the direct
measurement of systolic BP (SBP), diastolic BP (DBP) and
PP [17–19]. Briefly, male rats were implanted at 12 weeks of
age with 1-week recovery, 5 weeks of baseline measure-
ments, followed by 3 weeks of 1% NaCl in the drinking
water. At sacrifice, weights for cardiac mass index (CMI),
left ventricular mass index (LVMI) and renal mass index
(RMI) were measured, and harvested tissues were snap-
frozen in liquid nitrogen and stored at808C or fixed in 4%
buffered formaldehyde and paraffin-embedded.
Urinary biochemistry analysis
On the day prior to sacrifice, rats were placed in metabolic
cages for 24 h urine collection and assessment of fluid
intake. Urine electrolytes were measured by routine bio-
chemical analysis (Gartnaval General Hospital). Urinary
protein was measured using Thermo Pierce Protein Assay
660 (#22662, Thermo Fisher Scientific Inc. (Paisley, Scot-
land, UK) according to manufacturer’s instructions. Urine
samples were diluted 1 in 5 for assay.
Renal histology
For renal histology, adjacent transverse sections of kidney
(3mm thick) were stained with haematoxylin and eosin
(H&E), elastin muscle fibrin stain (EMSB) or periodic acid
Schiff (PAS), and scored for renal changes according to a
previously described scoring system [18,20]. All images
shown were viewed on an Olympus BX51 microscope with
an attached Olympus DP72 digital camera and DP2-BSW
software. No colour correction or other manipulation of the
images was performed.
Gene expression profiling
Microarray gene expression profiling was used to identify
differentially expressed probe sets between male SHRSP,
SP.WKYGla3d, SP.WKYGla3f, and WKY rats 21 weeks of age
with and without 1% salt challenge. Whole kidneys were
homogenized and total RNA was extracted from 4 rats for
each strain using the miRNeasy kit according to the man-
ufacturer’s protocol (Qiagen, Manchester, UK). Total RNAs
were then treated with Turbo DNase-free kit (Ambion;
Thermo Fisher Scientific Inc.) quantified by Nanodrop
ND-1000 spectrophotometer and quality verified by Agilent
Bioanalyzer 2100 (Agilent Technologies, Stockport,
Cheshire, UK). Biotinylated, amplified target chromosomal
RNA was prepared using Illumina TotalPrep RNA Amplifi-
cation Kit (Ambion) and hybridized to the Illumina RatRef
Beadchips RatRef-12v1 as described by Illumina. After
hybridization, microarray chips were washed, stained
and scanned using Illumina BeadArray Reader, and nor-
malized using quantile normalization implemented in the
Illumina BeadStudio microarray analysis software. Gene
expression profiling between salt-loaded kidneys from
male SHRSP, WKY and congenic sub-strains SP.WKYGla3d
and SP.WKYGla3f (Illumina only) at 21 weeks old wereVolume 34  Number 1  Month 2016
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FIGURE 1 Congenic interval mapping based on physical locations of polymorphic microsatellite markers and SNPs in a panel of congenic sub-strains. Grey and white bars
indicate regions of WKY and SHRSP homozygosity, respectively, whereas hatched bars indicate areas containing a recombination. The location of previously identified
systolic blood pressure (SBP), diastolic blood pressure (DBP) and pulse pressure (PP) loci [18] is indicated to the right of the figure. Mean change in baseline and salt-loaded
SBP in comparison to the SHRSP parental strain is illustrated below each of the respective congenic sub-strains. P<0.05, P<0.001 versus SHRSP for baseline and salt
challenge, respectively. SHRSP, stroke-prone spontaneously hypertensive; WKY, Wistar–Kyoto.
Blood pressure locus on rat chromosome 3
Canalysed with analysis of variance (ANOVA) by Partek
Genomic suite with a cut-off of false discovery rate
(FDR) less than 0.05. In addition, previously published
Affymetrix Rat Genome 230 2.0 Array gene expression data
(24) were used to identify additional differentially
expressed probe sets between SHRSP and WKY strains
within the congenic interval. Data were normalized with
Robust Multiarray Average method conducted on Partek
Genomic suite software (http://www.partek.com/). The
integration of different gene expression chip platforms
were used to maximize the efficiency to detect differently
expressed genes that map to the congenic region of
chromosome 3. The microarray data set generated by
Affymetrix chip was previously reported and submitted
to Array Express (accessible at http://www.ebi.ac.uk/)
(Experimental Accession No. E-MEXP-2514).
Quantitative real-time PCR
Total RNA samples were extracted from kidneys using
miRNeasy kits (Qiagen), treated with Turbo DNase FreeJournal of Hypertension
opyright © 2016 Wolters Kluwer Health, Inc. Unau(Ambion) and quantified using NanoDrop ND-1000
spectrophotometer. The gene expression levels were
assessed at 5, 16 and 21 weeks of age  salt challenge
by Taqman assays. FAM-labelled TaqMan probes for Dnm1
(Rn00589865_m1), Tor1b (Rn01439013_m1) and Rabgap1
(Rn00525120_m1) were duplexed with b-actin (4352340E;
VIC-labelled), when appropriate. Expression of genes nor-
malized to expression of b-actin in each sample was
derived using the comparative (DDCT) method, with salt-
challenged 21-week-old SHRSP as calibrator strain, and
expressed as fold-changes.
Interrogation of next-generation sequencing
data for SHRSP and WKY strains
To further dissect the BP QTL on chromosome 3 on
a genome level, high-throughput NGS of SHRSPGla and
WKYGla strains [21] was examined. Illumina paired-end
reads of SHRSPGla and WKYGla were previously submitted
to EBI Sequence Read archive with accession number
ERP002160 as reported [21]. Reads were mapped to thewww.jhypertension.com 3
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Koh-Tan et al.Brown Norway rat reference genome with Burrows
Wheeler Aligner and variants were called using Genome
Analysis Tool kit and annotated with Ensembl Variant Effect
Predictor as previously described [21]. Non-synonymous
and frame-shift mutations along with their predicted effect
were identified within the respective in-common and
unique congenic intervals on chromosome 3 using the
Sorting Intolerant From Tolerant (SIFT) algorithm [22].
Statistical analysis
Results are shown as mean standard error of mean (SEM),
unless otherwise stated. Haemodynamic parameters of
WKY or congenic strains were compared to the untreated
SHRSP using repeated-measures ANOVA, general linear
model with Dunnett’s post-hoc test, as described previously
[18]. F statistics and P values corresponding with the main
effects for the strain are reported. Histology scores for each
group were compared using the Kruskal–Wallis test,
adjusted for ties. Bonferroni-corrected Mann–Whitney tests
were then used for testing significance between group
pairs. Gene expression comparison was done for each time
point and treatment group using ANOVAwith Tukey’s post-
hoc test. Effects of salt challenge on gene expression at
21 weeks of age for each strain were compared using t test.
Comparison of all other data between WKY or congenic
strains and SHRSP was carried out using one-way ANOVA
with Dunnett’s post-hoc test, with SHRSP as control strain.
RESULTS
Haemodynamic parameters of congenic strains
A panel of seven congenic strains generated on the SHRSP
genetic background containing WKY-introgressed RNO3
segments of varying size is illustrated in Fig. 1. Five of the
overlapping congenic intervals were focused within the
first 50Mbp of RNO3, encompassing the previously ident-
ified PP QTL [13]. For clarity of illustration, haemodynamic
profiles for the seven congenic strains have been arbitrarily
split into two groups (group A: SP.WKYGla3a, SP.WKYGla3d,
SP.WKYGla3f, and group B: SP.WKYGla3b, SP.WKYGla3c,
SP.WKYGla3e, SP.WKYGla3g). Baseline SBP, DBP and PP in
WKY, SP.WKYGla3a, SP.WKYGla3d and SP.WKYGla3e rats
were significantly reduced compared to SHRSP (Table 1,
Figs. 2 and 3). Baseline SBP and DBP, but not PP, in
SP.WKYGla3c rats were significantly reduced compared toTABLE 1. Statistics for baseline and salt-challenged haemodynamic m
Baseline (weeks 13–17)
Congenic strains
(no. of rats) Systolic BP Diastolic BP Pulse pre
SHRSP (n¼26) – – –
WKY (n¼13) F¼152.96, P<0.001 F¼90.99, P<0.001 F¼96.85, P<
SP.WKYGla3a (n¼10) F¼17.14, P<0.001 F¼10.99, P¼0.002 F¼9.01, P¼
SP.WKYGla3b (n¼6) F¼1.77, P¼0.193 F¼2.92, P¼0.97 F¼0.08, P¼
SP.WKYGla3c (n¼5) F¼7.20, P¼0.012 F¼5.31, P¼0.028 F¼2.70, P¼
SP.WKYGla3d (n¼7) F¼23.64, P<0.001 F¼16.24, P<0.001 F¼11.97, P¼
SP.WKYGla3e (n¼9) F¼28.47, P<0.001 F¼11.83, P¼0.002 F¼6.63, P¼
SP.WKYGla3f (n¼6) F¼1.09, P¼0.305 F¼0.92, P¼0.344 F¼0.31, P¼
SP.WKYGla3g (n¼7) F¼0.04, P¼0.843 F¼0.35, P¼0.561 F¼0.54, P¼
BP, blood pressure; SHRSP, stroke-prone spontaneously hypertensive; WKY, Wistar–Kyoto.
4 www.jhypertension.com
Copyright © 2016 Wolters Kluwer Health, Inc. UnauSHRSP. Baseline SBP, DBP and PP in SP.WKYGla3b,
SP.WKYGla3f and SP.WKYGla3g strains were not signifi-
cantly different compared to SHRSP. Salt-challenged
SBP, DBP and PP in WKY, SP.WKYGla3a, SP.WKYGla3c,
SP.WKYGla3d and SP.WKYGla3e rats were significantly
reduced compared to SHRSP (Table 1, Figs. 2 and 3).
Salt-challenged SBP and DBP, but not PP, in SP.WKYGla3b
and SP.WKYGla3f rats were significantly reduced compared
to SHRSP. Salt-challenged SBP, DBP and PP in SP.WKYGla3g
rats were not significantly different compared to SHRSP.
Salt challenge in the SHRSP results in exaggerated night-
day PP difference [night PP (mmHg)day PP (mmHg)] and
similar effects were observed in the SP.WKYGla3b, SP.WKY-
Gla3f and SP.WKYGla3g congenic strains (Fig. 2c and d, Fig. 3c
and d), whereas SP.WKYGla3a, SP.WKYGla3c, SP.WKYGla3d
and SP.WKYGla3e strains displayed significantly reduced
diurnal variation similar to WKY strains during salt
challenge.
Cardiac, left ventricular and renal mass indices
Cardiac mass index, LVMI and RMI for SHRSP, WKY and
congenic strains are shown in Table 2. CMI and LVMI of
WKY, SP.WKYGla3a, SP.WKYGla3c, SP.WKYGla3d and
SP.WKYGla3e rats were significantly lower compared to
SHRSP rats. CMI and LVMI from SP.WKYGla3b, SP.WKYGla3f
and SP.WKYGla3g rats were not significantly different from
SHRSP rats. RMI was significantly lower in WKY and
SP.WKYGla3a strains, compared to SHRSP rats, but not in
any of the congenic sub-strains.
Renal histopathology and biochemistry
Renal histology (Fig. 4a) and histopathology scoring
(Fig. 4b) identified extensive pathological changes, includ-
ing vascular changes consistent with accelerated hyperten-
sion in kidneys from salt-challenged SHRSP and
SP.WKYGla3f strains. However, normal renal morphology
was observed in WKY, SP.WKYGla3a and SP.WKYGla3d
strains despite salt challenge.
Increased renal pathology scores were paralleled by
elevated proteinuria levels in SHRSP and SP.WKYGla3f
compared to WKY, SP.WKYGla3a and SP.WKYGla3d rats
(P< 0.001).
Urine biochemistry and 24-h drinking volumes in salt-
challenged SHRSP, WKY and congenic rats are given ineasurements
Salt-challenged (weeks 18–21)
ssure Systolic BP Diastolic BP Pulse pressure
– – –
0.001 F¼195.41, P<0.001 F¼133.53, P<0.001 F¼70.59, P<0.001
0.005 F¼44.84, P<0.001 F¼39.14, P<0.001 F¼6.781, P¼0.014
0.778 F¼5.88, P¼0.022 F¼9.32, P¼0.005 F¼1.40, P¼0.245
0.111 F¼25.32, P<0.001 F¼18.45, P<0.001 F¼9.40, P¼0.005
0.002 F¼39.20, P<0.001 F¼31.67, P<0.001 F¼10.90, P¼0.002
0.015 F¼55.73, P<0.001 F¼35.16, P<0.001 F¼8.36, P¼0.007
0.583 F¼4.79, P¼0.037 F¼5.09, P¼0.032 F¼0.01, P¼0.916
0.468 F¼0.70, P¼0.409 F¼1.61, P¼0.213 F¼1.37, P¼0.251
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FIGURE 2 Haemodynamic measurements of selected congenic sub-strains. Baseline and salt-challenged (a) systolic blood pressure, (b) diastolic blood pressure, and (c) pulse
pressure in WKY, SHRSP and congenic sub-strains. Data illustrated are weekly averaged night-time and day-time data points; (d) salt-challenged night-day differences in
pulse pressure. P<0.001 versus SHRSP. SHRSP, n¼10; SP.WKYGla3a, n¼8; SP.WKYGla3d, n¼12; SP.WKYGla3f, n¼6; WKY, n¼12.
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FIGURE 3 Haemodynamic measurements of selected congenic sub-strains. Baseline and salt-challenged (A) systolic blood pressure, (b) diastolic blood pressure, (C) pulse
pressure and (D) pulse pressure diurnal variation of congenic sub-strains and WKY were compared to SHRSP rats. SHRSP, n¼10; SP.WKYGla3b, n¼6; SP.WKYGla3c,
n¼12; SP.WKYGla3e, n¼12; SP.WKYGla3 g, n¼6; WKY, n¼12. SHRSP, stroke-prone spontaneously hypertensive; WKY, Wistar–Kyoto.
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TABLE 2. Cardiac, left ventricular and renal mass indices
Cardiac mass index (mg/g) Left ventricular mass index (mg/g) Renal mass index (mg/g)
SHRSP (n¼16–34) 4.660.40 3.640.39 4.110.25
WKY (n¼12–32) 3.480.26a 2.520.20a 2.870.23a
SP.WKYGla3a (n¼16–19) 4.030.28a 3.040.29a 3.650.20a
SP.WKYGla3b (n¼6) 4.470.27 3.330.33 3.780.18
SP.WKYGla3c (n¼4–5) 3.880.12a 2.790.14a 3.770.12
SP.WKYGla3d (n¼7) 4.070.17a 3.000.11a 3.770.15
SP.WKYGla3e (n¼12–13) 4.260.30a 3.120.24a 4.160.40
SP.WKYGla3f (n¼7–11) 4.720.64 3.570.66 4.250.70
SP.WKYGla3g (n¼5–7) 4.670.40 3.280.19 4.200.62
P value <0.001 <0.001 <0.001
SHRSP, stroke-prone spontaneously hypertensive; WKY, Wistar–Kyoto.
aStrain is significantly different from SHRSP.
Koh-Tan et al.Table 3. In a 24-h period, SHRSP and SP.WKYGla3f rats
drank significantly more and produced significantly more
urine than WKY, SP.WKYGla3a and SP.WKYGla3d rats. Uri-
nary Naþ, Kþ, urea and creatinine concentrations were
significantly lower in SHRSP and SP.WKYGla3f compared
to WKY, SP.WKYGla3a and SP.WKYGla3d rats.
Identification of positional candidate genes
Analysis of the Illumina BeadChip expression data ident-
ified two significantly differentially expressed genesWKY
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FIGURE 4 Renal phenotypes. (a) Representative histology images of H&E-stained kidneys
normal arteries (A), glomeruli (G) and tubules (T). In contrast, the representative images
vascular changes demonstrating necrosis of the wall (N) with haemorrhage into the surro
(TA). Glomeruli (G) show ischaemic changes, but no specific lesions. Magnification¼100
(c) proteinuria (n¼6–11/group).  P<0.001 versus SHRSP. H&E, haematoxylin and eosin
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Copyright © 2016 Wolters Kluwer Health, Inc. Unaumapping to the region in common between the SP.WKY-
Gla3d and SP.WKYGla3f congenic strains. These genes are
dynamin1 (Dnm1) and torsin family 1, member B (Tor1b).
Dnm1 expression was significantly reduced and Tor1b
expression significantly increased in kidneys from SHRSP
compared to WKY, SP.WKYGla3d and SP.WKYGla3f
congenic sub-strains (Supplementary Table 2, http://links.
lww.com/HJH/A685). In the Affymetrix GeneChip expres-
sion data GTPase, activating protein 1 (Rabgap1) was the
only gene significantly differentially expressed between the3f
SHRSP
(b)
(c)
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of WKY, SP.WKYGla3a and SP.WKYGla3d rats, where the renal parenchyma shows
of the typical areas of the kidneys of SHRSP and SP.WKYGla3f rats display major
unding tissue, arterioles with severe hyalinosis (H) and areas of tubular atrophy
; Scale bar¼100mm. (b) Renal histopathology scores (n¼7–11/group) and
; SHRSP, stroke-prone spontaneously hypertensive; WKY, Wistar–Kyoto.
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TABLE 3. Renal biochemistry (24-h urine)
SHRSP (n¼17) WKY (n¼18) 3a (n¼9) 3d (n¼7) 3f (n¼6) P value
Volume drank (ml) 78.6221.79 53.1230.74a 58.479.43 57.5515.23 79.1616.78 0.010
Urine volume (ml) 55.2915.78 31.8014.34a 34.037.02a 30.6811.32a 55.868.67 <0.001
Na (mmol/l) 211.1446.41 220.2371.19 268.9732.70a 260.4936.69 169.8927.46 0.004
K (mmol/l) 44.4817.37 71.2533.04a 72.4120.37a 80.7227.00a 28.258.59 <0.001
Urea (mmol/l) 131.1657.62 235.5290.62a 228.9362.26a 316.61113.57a 103.0034.23 <0.001
Creatinine (mmol/l) 1.710.69 3.471.32a 2.600.45 3.090.90a 1.340.38 <0.001
Na/creatinine 180.5187.06 70.0530.37a 105.1815.73a 89.7624.74a 131.4924.69 <0.001
K/creatinine 37.579.75 20.856.48a 27.624.32a 26.154.13a 21.102.41a <0.001
Urea/creatinine 112.6929.95 68.859.11a 87.3312.81a 101.158.47 76.344.14a <0.001
SHRSP, stroke-prone spontaneously hypertensive; WKY, Wistar–Kyoto.
aStrain is significantly different from SHRSP.
Blood pressure locus on rat chromosome 3
Cparental strains that mapped to the unique SP.WKYGla3d
congenic interval (Supplementary Table 3, http://links.
lww.com/HJH/A685). The Illumina RatRef Beadchip
RatRef-12v1 does not contain a probe that targets the
Rabgap1 gene.*
†
*
†
* *
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FIGURE 5 Gene expression of (a) Dnm1, (b) Tor1b and (c) Rabgap1 at 5, 16 and
21 weeks of age with (21wk-S) and without (21wk-NS) salt challenge in kidneys
from WKY, SHRSP, SP.WKYGla3d and SP.WKYGla3f rats.
P<0.05 versus SHRSP,
P<0.001 versus SHRSP, P<0.05 versus SP.WKYGla3f. RQ¼ relative quanti-
tation; SHRSP, stroke-prone spontaneously hypertensive; WKY, Wistar–Kyoto.
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The microarray expression profiling data for the prioritized
genes Dnm1, Tor1b and Rabgap1 was validated by quan-
titative real-time PCR (qPCR) (Fig. 5). Expression of Dnm1
was significantly higher in WKY, SP.WKYGla3d and
SP.WKYGla3f kidneys compared to SHRSP at 5, 16 and
21 weeks with and without salt challenge (P< 0.001).
Expression of Tor1b was significantly lower in WKY,
SP.WKYGla3d and SP.WKYGla3f strains compared to SHRSP
rats at all time points investigated with and without salt
challenge (P< 0.001). Expression of Rabgap1was higher in
WKY and SP.WKYGla3d strains at all time points, but was
statistically significantly only in WKY rats at 16 weeks of age
(P¼ 0.038), in SP.WKYGla3d rats at 21 weeks of age
without salt challenge (P¼ 0.001) and in both WKY and
SP.WKYGla3d rats at 21 weeks with salt challenge
(P¼ 0.002). Expression of Rabgap1 in SP.WKYGla3f rats
was similar to SHRSP rats at all time points, and there
was no difference in the expression of Dnm1 and Rabgap1
when compared at 21 weeks with and without salt
challenge.
Analysis of next-generation sequencing data
Examination of NGS sequence variants between SHRSPGla
and WKYGla identified single-nucleotide polymorphisms
(SNPs), and insertions and deletions of DNA segments
(INDEL) in the RNO3 congenic intervals which are in
common between the SP.WKYGla3d and SP.WKYGla3f
strains, or unique to SP.WKYGla3d strain when compared
to the SP.WKYGla3f strain. These variants are summarized in
Tables 4 and 5, respectively. Non-synonymous and frame-
shift mutations along with their predicted effect were ident-
ified using the SIFT algorithm (Supplementary Tables 4 and
5, http://links.lww.com/HJH/A685). Within the in-common
region, there are 18 genes which contain sequence variants
(non-synonymous or frame-shift) predicted to have dele-
terious or potentially deleterious functional effects. Within
the unique region, there are 25 genes containing sequence
variants predicted to have an effect on protein function.
Supplementary Table 6 (http://links.lww.com/HJH/A685)
summarizes the NGS sequence variants specific to the three
prioritized genes (Dnm1, Tor1b, Rabgap1) that are signifi-
cantly differently expressed within the RNO3 BP QTL.
GWAS Central [23] confirmed that none of the genes ident-
ified by microarray expression profiling or NGS was pre-
viously implicated in human genetic association studies.www.jhypertension.com 7
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TABLE 4. WKYGla versus SHRSPGla NGS sequence variants on RNO3 within the region in-common between congenic strains 3d and 3f
SNP consequences INDEL consequences
INTERGENIC 1930 INTERGENIC 406
UPSTREAM 808 UPSTREAM 171
DOWNSTREAM 711 DOWNSTREAM 134
3PRIME_UTR 74 3PRIME_UTR 4
5PRIME_UTR 15 5PRIME_UTR 0
INTRONIC 3946 INTRONIC 805
SYNONYMOUS_CODING 77 SYNONYMOUS_CODING 0
NON_SYNONYMOUS_CODING 33 NON_SYNONYMOUS_CODING 2
STOP_GAINED 0 FRAMESHIFT_CODING 1
STOP_LOST 0 COMPLEX_INDEL 0
ESSENTIAL_SPLICE_SITE 2 ESSENTIAL_SPLICE_SITE 0
SPLICE_SITE 13 SPLICE_SITE 1
WITHIN_MATURE_miRNA 0 WITHIN_MATURE_miRNA 0
WITHIN_NON_CODING_GENE 8 WITHIN_NON_CODING_GENE 0
NGS, next-generation sequencing; RNO3, rat chromosome 3; SHRSP, stroke-prone spontaneously hypertensive; SNP, single-nucleotide polymorphism; WKY, Wistar–Kyoto.
Koh-Tan et al.DISCUSSION
Previously we confirmed SBP, DBP and PP QTLs on RNO3
[18]. In this study, we have further dissected and narrowed
the congenic interval with the production of six sub-
strains (SP.WKYGla3b–SP.WKYGla3g), each containing
smaller introgressed WKY genome segments. Three of
these sub-strains (SP.WKYGla3c, SP.WKYGla3d and
SP.WKYGla3e) demonstrated significantly reduced SBP,
DBP and PP at baseline and during salt challenge, whereas
the SP.WKYGla3f strain demonstrated significantly
reduced SBP and DBP during salt challenge only. In
contrast, SP.WKYGla3g rats did not differ in haemody-
namic response from the SHRSP rats. This indicates that
the approximate 7.8-Mbp region (rs65518414–
rs13455504) contains genetic elements responsible for
regulation of SBP and DBP during salt challenge, whereas
the region between rs197649383-D3Wox3 (17Mbp)
contains genetic elements responsible for regulation of
PP variation. The SP.WKYGla3e strain encompasses a
region overlapping that reported for BP [24] and CMI
[25] QTL in Dahl salt-sensitive (DS) rats.TABLE 5. WKYGla versus SHRSPGla NGS sequence variants on RNO3 wit
congenic strain
SNP consequences
INTERGENIC 11468
UPSTREAM 969
DOWNSTREAM 1022
3PRIME_UTR 30
5PRIME_UTR 5
INTRONIC 3895
SYNONYMOUS_CODING 64
NON_SYNONYMOUS_CODING 59
STOP_GAINED 0
STOP_LOST 0
ESSENTIAL_SPLICE_SITE 2
SPLICE_SITE 10
WITHIN_MATURE_miRNA 0
WITHIN_NON_CODING_GENE 27
NGS, next-generation sequencing; RNO3, rat chromosome 3; SHRSP, stroke-prone spontaneous
8 www.jhypertension.com
Copyright © 2016 Wolters Kluwer Health, Inc. UnauIn addition, we have identified a BP locus for SBP and
DBP regulation during salt challenge in the region of
D3Mgh6–D3Rat114. This overlaps with loci identified for
BP in the DS [25], Fawn-Hooded hypertensive (FHH) [26]
and SHR rats [27]. However, this locus is distinct from two
additional BP QTLs previously identified and confirmed in
DS rats [28,29].
In the present study, significant reductions in LVMI and
CMI were identified in the SP.WKYGla3a, SP.WKYGla3c,
SP.WKYGla3d and SP.WKYGla3e congenic sub-strains when
compared to SHRSP. These reductions in CMI and LVMI
occurred in parallel with observed BP reductions (SBP, DBP
and PP) during salt challenge. In contrast, the sub-strains
showing no significant reduction in PP during salt challenge
(SP.WKYGla3b, SP.WKYGla3f and SP.WKYGla3g) also dem-
onstrated no significant reduction in CMI or LVMI. The
region incorporating SP.WKYGla3c, SP.WKYGla3d and
SP.WKYGla3e intervals (rs65518414-D3Wox2) coincides
with a region harbouring cardiac hypertrophy QTL
reported in DS, SHR and SHRSP rats [30,31], which overlap
a QTL for SBP [30]. A loss-of-function mutation in endonu-
clease G (Endog), located at 3p12, has previously beenhin the region unique to congenic strain 3d when compared to 3f
INDEL consequences
INTERGENIC 1879
UPSTREAM 153
DOWNSTREAM 162
3PRIME_UTR 11
5PRIME_UTR 0
INTRONIC 701
SYNONYMOUS_CODING 0
NON_SYNONYMOUS_CODING 0
FRAMESHIFT_CODING 5
COMPLEX_INDEL 0
ESSENTIAL_SPLICE_SITE 0
SPLICE_SITE 3
WITHIN_MATURE_miRNA 0
WITHIN_NON_CODING_GENE 3
ly hypertensive; WKY, Wistar–Kyoto.
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Blood pressure locus on rat chromosome 3
Cassociated with increased LVM and impaired cardiac func-
tion in SHR rats [32]. The present data do not support Endog
as a functional candidate for LVMI in the SHRSP model,
because although Endog is derived from WKY in the
SP.WKYGla3f and SP.WKYGla3g rats, there is no improve-
ment in CMI or LVMI in these sub-strains. In the Endog
study, detailed baseline cardiac phenotyping and func-
tional analysis was performed in younger rats in the
absence of salt challenge, which may account for the
discrepancy with our current findings. Further cardiac
phenotyping and functional studies in the sub-strains at
baseline will be necessary to establish if reduced cardiac
hypertrophy is a consequence of reduced PP or results from
an independent cardiac mass QTL. A QTL for RMI was
previously reported in an F2 cross between SHR  Brown
Norway rats at marker D3Mit9 [33], overlapping the lower
end of SP.WKYGla3d recombination region. In our study,
significant reduction of RMI was observed in SP.WKYGla3a,
but not for any of the congenic sub-strains.
Our data show that the 17-Mbp region (rs197649383-
D3Rat80), unique to the SP.WKYGla3d strain, plays a role in
salt-induced renal pathology as demonstrated by the
attenuation of proteinuria and lack of histopathological
changes during salt challenge in sub-strains harbouring
WKY alleles in this interval. This region is distinct from a
proteinuria QTL reported previously in Sabra rats [34].
Whether an improvement in electrolyte resorption and
excretion plays a role needs to be further investigated
through renal function assays such as direct glomerular
filtration rate (GFR) measurements, as well as electrolyte
measurements in plasma.
Using a combination of microarray expression profiling
and qPCR, we have identified two candidate genes, Dyna-
min1 (Dnm1) and Torsin1b (Tor1b), for BP regulation,
which map to the common region shared by SP.WKYGla3d
and SP.WKYGla3f strains. Moreover, we have identified
a candidate gene for salt-induced PP variability and
renal pathology within the 17-Mbp region unique to the
SP.WKYGla3d strain, Rabgap1. The proteins encoded by the
three identified candidate genes are members of protein
families that regulate cellular membrane dynamics, notably
vesicle trafficking and recycling.Dnm1 encodes Dynamin1,
a membrane remodelling GTPase protein that predomi-
nantly exists as a homodimer and plays a crucial role in
clarthrin-mediated endocytosis, that is, the budding process
and recycling of synaptic vesicles [35–37]. Using mouse
brain stem synapses, Lou et al. [37] showed that the endo-
cytic rate of synapses in Dynamin1 knockout mice was
normal when given small stimuli; however, when the
stimulation was increased, endocytic rate quickly saturated
and was overtaken by the exocytosis rate. The significant
reduction in Dnm1 observed in the SHRSP (Fig. 5) may be
responsible for an overspill of the renal sympathetic nerv-
ous system in this model. With reduced Dnm1 levels, the
rate of neurotransmitter release (exocytosis) in the pre-
synaptic nerve endings may be in excess of the rate of
uptake (endocytosis) leading to a prolongation of the
sympathetic stimulus at the synaptic cleft. An increased
sympathetic signal within renal neurons could result in
elevated BP in response to salt challenge. Although further
functional evidence would be required to confirm thisJournal of Hypertension
opyright © 2016 Wolters Kluwer Health, Inc. Unauhypothesis, several animal studies have already demon-
strated a role of the renal sympathetic nervous system (SNS)
in salt-induced hypertension. For example, salt loading
increases renal SNS activity in deoxycorticosterone
acetate-salt rats [38], and renal denervation has been shown
to prevent salt-induced increase in BP in Dahl S salt-sensi-
tive rats [39]. An alternative kidney-specific role for Dyna-
min has also been identified in the maintenance of cellular
architecture of glomerular podocytes [40]. Dysfunction of
these specialized epithelial cells can lead to failure of the
glomerular filtration barrier and proteinuria [41].
Tor1B encodes TorsinB protein, which localizes within
the perinuclear membrane and cytoplasmic endoplasmic
reticulum, and functions as a molecular chaperone
that assists in conformational folding of the membrane
[42,43]. TorsinB has not previously been linked to kidney
function or BP regulation; however, similarly to Dnm1,
members of the Torsin family of proteins have been
implicated in synaptic vesicle recycling. For example,
polymorphisms in the TOR1A/TOR1B region are
associated with torsion dystonia, a neurological disorder
characterized by debilitating muscle contractions [44]. It
has been demonstrated that Torsin-induced enhancement
of synaptic vesicle recycling contributes to dystonia
pathophysiology [45].
Rabgap1 encodes Rab GTPase activator protein 1, which
catalyses the hydrolysis of GTP to GDP leading to inhibition
of the active state of the Rab protein. RabGAPs act as key
regulatory nodes, integrating signalling involved in the
precise coordination of budding, transport and fusion of
vesicles [46,47]. Rab proteins have been identified as a
component of aldosterone-dependent epithelial sodium
channel (ENaC) trafficking, playing an important role in
the regulation of ENaC density at the apical membrane of
the epithelial cell of the collecting duct and Naþ reabsorp-
tion [48,49]. Inhibition of GTPase activating protein activity
leads to Rab activation, which permits forward trafficking of
the ENaC channel to the apical surface to augment Naþ
absorption [49]. In the present study, the significant increase
in renal expression of Rabgap1 in WKY and SP.WKYGla3d
congenic rats with age and salt challenge may represent a
normal response of Rabgap1 to maintain sodium homeo-
stasis and normotensive BP levels. In contrast, SHRSP and
SP.WKYGla3f congenic rats demonstrate significantly lower
renal expression of Rabgap1,whichmay indicate enhanced
apical membrane ENaC density and augmented Naþ
reabsorption. The potential impact of deficient Rabgap1
activity on renal pathology observed in SHRSP and the
SP.WKYGla3f congenic strain requires further functional
investigation.
In addition to the three candidate genes prioritized by
significant differential expression, we have also identified
59 genes by NGS within the RNO3 BP QTL region, which
contain sequence variants predicted to have an effect on
protein function. These variants will require validation by
capillary sequencing prior to future investigation; however,
there is no evidence of differential expression in these
genes. Although it will be necessary to assess all of the
59 listed genes with non-synonymous variants, priority may
be given to early investigation of two genes (Kynu and
Ccbl1), which have been previously linked to BP regulationwww.jhypertension.com 9
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Koh-Tan et al.in spontaneously hypertensive rats [50–52], along with a
further two genes (Crb2 and Ralgps1), which have been
linked with regulation of the glomerular filtration barrier in
zebrafish [53].
In conclusion, the current study identifies distinct inter-
vals on RNO3 containing both differentially expressed
genes and genes that contain sequence variants with poten-
tial functional importance, which may be implicated in BP
regulation and salt-induced renal pathology. Future mech-
anistic analysis of these implicated genes will determine
their role in the BP regulation and renal pathology resulting
from salt challenge in the SHRSP rat. Understanding the
functional role of these genes will be important for develop-
ment of novel therapeutic strategies for human essential
hypertension and salt-induced renal damage.
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Referee 1
Strength: The present work, as a follow up of previous
findings, provides more detailed information on the role
of rat chromosome 3 genetic loci on blood pressure regu-
lation by identifying selected differentially expressed genes
and genes containing sequence variants. It stimulates future
work to explain the functional relevance of the identified
genes, andof their sequencevariants. Themajorweakness of
the study is the lack of evidence that none of the identified rat
genes was previously implicated in human hypertension,
particularly when considering that the SHRSP is a suitable
animal model for the human hypertensive disease.Referee 2
Strengths and weaknesses of the article: The study illus-
trates the contributions of rat chromosome 3 (RNO3)
genetic loci on salt-induced high blood pressure and renal
pathology. In RNO3, Dynamin1, Torsin1b and Rabgap1
were identified as candidate genes for salt sensitivity.
The proteins encoded by these genes are known to be
associated with membrane protein trafficking, however,
the molecular targets or signaling pathway affected by
these proteins are not clear. Further investigation may
be required to study the cellular signaling and/or phys-
iological effect such as sympathetic nervous activity in the
RNO3 congenic substrains of SHRSP or its mimetic model
in vitro.www.jhypertension.com 11
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